DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

Brain

Volumn 133, Issue 3, 2010, Pages 713-726

  Hong, Zhen ^a,b   Shi, Min ^a   Chung, Kathryn A ^c   Quinn, Joseph F ^c   Peskind, Elaine R ^a,d   Galasko, Douglas ^e   Jankovic, Joseph ^f   Zabetian, Cyrus P ^a,d   Leverenz, James B ^a,d   Baird, Geoffrey ^a   Montine, Thomas J ^a   Hancock, Aneeka M ^a   Hwang, Hyejin ^a   Pan, Catherine ^a   Bradner, Joshua ^a   Kang, Un J ^g   Jensen, Poul H ^h   Zhang, Jing ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SICHUAN UNIVERSITY   (China)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h AARHUS UNIVERSITY   (Denmark)

Author keywords

synuclein; Biomarker; Cerebrospinal fluid; DJ 1; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; DJ 1 PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD DISEASE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GEL FILTRATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BLOOD; CEREBROSPINAL FLUID; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PARKINSON DISEASE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; YOUNG ADULT;

EID: 77950223687     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq008     Document Type: Article

References (33)

1. Amenta F, Barili P, Bronzetti E, Felici L, Mignini F, Ricci A. Localization of dopamine receptor subtypes in systemic arteries. Clin Exp Hypertens 2000; 22: 277-288
2. Borghi R, Marchese R, Negro A, Marinelli L, Forloni G, Zaccheo D, et al. Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci Lett 2000; 287: 65-67
3. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
4. Burn DJ, Lees AJ. Progressive supranuclear palsy: where are we now? Lancet Neurol 2002; 1: 359-369
5. Choi J, Sullards MC, Olzmann JA, Rees HD, Weintraub ST, Bostwick DE, et al. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 2006; 281: 10816-10824
6. Dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 2005; 66: 175-191
7. El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA, et al. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. Faseb J 2006; 20: 419-425
8. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004; 351: 2498-2508
9. Fjorback AW, Varming K, Jensen PH. Determination of alpha-synuclein concentration in human plasma using ELISA. Scand J Clin Lab Invest 2007; 67: 431-435
10. Galvin JE, Lee VM, Trojanowski JQ. Synucleinopathies: clinical and pathological implications. Arch Neurol 2001; 58: 186-190
11. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 228-234
12. Hong Z, Zhang QY, Liu J, Wang ZQ, Zhang Y, Xiao Q, et al. Phosphoproteome study reveals Hsp27 as a novel signaling molecule involved in GDNF-induced neurite outgrowth. J Proteome Res 2009; 8: 2768-2787
13. Jin J, Davis J, Zhu D, Kashima DT, Leroueil M, Pan C, et al. Identification of novel proteins affected by rotenone in mitochondria of dopaminer-gic cells. BMC Neurosci 2007; 8: 67.
14. Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K. The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy. J Neural Transm 2006; 113: 1435-1439
15. Li QX, Campbell BC, McLean CA, Thyagarajan D, Gai WP, Kapsa RM, et al. Platelet alpha-and gamma-synucleins in Parkinson's disease and normal control subjects. J Alzheimers Dis 2002; 4: 309-315
16. Li QX, Mok SS, Laughton KM, McLean CA, Cappai R, Masters CL, et al. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease. Exp Neurol 2007; 204: 583-588
17. Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB, et al. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 2004; 279: 12924-12934
18. Liu J, Hong Z, Ding J, Liu J, Zhang J, Chen S. Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies. J Proteome Res 2008; 7: 2033-2049
19. Lucking CB, Brice A. Alpha-synuclein and Parkinson's disease. Cell Mol Life Sci 2000; 57: 1894-1908
20. Maita C, Tsuji S, Yabe I, Hamada S, Ogata A, Maita H, et al. Secretion of DJ-1 into the serum of patients with Parkinson's disease. Neurosci Lett 2008; 431: 86-89
21. Meulener MC, Graves CL, Sampathu DM, Armstrong-Gold CE, Bonini NM, Giasson BI. DJ-1 is present in a large molecular complex in human brain tissue and interacts with alpha-synuclein. J Neurochem 2005; 93: 1524-1532
22. Michell AW, Luheshi LM, Barker RA. Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease. Neurosci Lett 2005; 381: 294-298
23. Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, Pepivani I, et al. Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 2008; 213: 315-325
24. Mollenhauer B, Trenkwalder C, von Ahsen N, Bibl M, Steinacker P, Brechlin P, et al. Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia. Dement Geriatr Cogn Disord 2006; 22: 200-208
25. Nural H, He P, Beach T, Sue L, Xia W, Shen Y. Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients. Mol Neurodegener 2009; 4: 23.
26. Ohrfelt A, Grognet P, Andreasen N, Wallin A, Vanmechelen E, Blennow K, et al. Cerebrospinal fluid alpha-synuclein in neurodegen-erative disorders-a marker of synapse loss? Neurosci Lett 2009; 450: 332-335
27. Spies PE, Melis RJ, Sjogren MJ, Rikkert MG, Verbeek MM. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. J Alzheimers Dis 2009; 16: 363-369
28. Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM, et al. Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease. Biochem Biophys Res Commun 2006; 349: 162-166
29. van Geel WJ, Abdo WF, Melis R, Williams S, Bloem BR, Verbeek MM. A more efficient enzyme-linked immunosorbent assay for measurement of alpha-synuclein in cerebrospinal fluid. J Neurosci Methods 2008; 168: 182-185
30. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000; 243: 243-255
31. Waragai M, Nakai M, Wei J, Fujita M, Mizuno H, Ho G, et al. Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease. Neurosci Lett 2007; 425: 18-22.
32. Waragai M, Wei J, Fujita M, Nakai M, Ho GJ, Masliah E, et al. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochem Biophys Res Commun 2006; 345: 967-972
33. Westerlund M, Belin AC, Anvret A, Hakansson A, Nissbrandt H, Lind C, et al. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. Faseb J 2008; 22: 3509-3514